Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06467786 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 21, 2024 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study is a prospective, multicenter, single arm Phase II exploratory study. It is expected to include 24 first-line patients with small cell lung cancer who have progressed after 6 months of treatment with platinum containing regimens, and receive treatment with irinotecan liposomes combined with cisplatin or carboplatin regimens.
Trial Details
NCT Number NCT06467786
Lead Sponsor Tang-Du Hospital
Conditions
(from sponsor)		 Small Cell Lung Cancer
Related terms Small Cell Lung Carcinoma
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov